Full video transcriptClick to expand
Auto-generated transcript of @el_farma_cologo's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Aver dis a . . .
- 0:01Appl For all the great things . . .
- 0:03Ok . . .
- 0:04Okay . . .
- 0:05Okay . . .
- 0:05Okay . . .
- 0:06Oh, I think.
- 0:07Oh, holy shit . . .
- 0:09Wow, that's super cool.
- 0:11Oh, okay.
- 0:11I will be exploring this.
- 0:13In Mexico, in Mexico,
- 0:16I was in the store.
- 0:18But even in the store.
- 0:20In Mexico, there was a new village from Chile . . .
- 0:22It's a red spot.
- 0:24And I was in Canada . . .
- 0:26But in the store.
- 0:27And I think in Canada . . . .
- 0:29It is so very little space, of weird enough,
- 0:32no eyes, no pictures, not just on the other side,
- 0:35but on the other side,
- 0:37of the other side, of even all products.
- 0:39It is very rare,
- 0:40so it is very famous for the live,
- 0:43it is very natural.
- 0:45But it is very Freeman's.
- 0:49I will be told by the case which means
- 0:51cultural policies by the command of many people.
- 0:54It is all famous.
- 0:56Okay.
- 0:57Okay.
- 0:59Okay.
- 3:02Oh, well, we've said, oh, wait, you were us.
- 3:04Pero, pero, lo que no teis en esquiano, as a poet, comer y voile,
- 3:08por que tocación y pique, pous nos la mis mezma.
- 3:11Ehm, que más ese estéri, el dígo tes esas un espectos,
- 3:16que pétanto para una sparrois en aapra,
- 3:18amé no importanta como tu fessiro, you know, se vece que pous amis,
- 3:20o deses estéri no me incantano.
- 3:22Eque pous esté no naturo fét estécular,
- 3:24itos estécos por en carcicititos, por que se pazas,
- 3:27The president says that it was just the cities that we have.
- 3:30It was very similar to the cities that we have.
- 3:34This was the first time I meet my friends in Paris,
- 3:38the first time I met Mexico,
- 3:41it was actually a very scientific community,
- 3:47and I got a similar responsibility to my friends in Paris,
- 4:24Okay.
- 4:26Okay.
- 4:57Okay.
- 4:58It's a part of the story.
- 4:59This was a story that I'm talking about about the sort of story that was done on my screen.
- 5:03A story that was written in theart of my screen.
- 5:07It's a story that was written in theart of my screen.
- 5:09I really liked it.
- 5:10Okay?
- 5:11It's a story that I done on my screen.
- 5:14If you like this story, subscribe to our channel.
- 5:17Thank you for watching this video.
- 5:19I'll be using this video to be useful to the audience for this film.
- 5:22and also, you know, the pattern almost quite a bit.
- 5:25In my expertise, we have to do that in the future.
- 5:29If I look at the video I have this tutorial,
- 5:31I'll be talking to the most of the editors,
- 5:33the informations team that are tutorials that you can see.
- 5:37And the same thing,
- 5:39the same thing there at many sites that I would like to see.
- 5:42And I'll also use the links in the link below.
- 5:44If you want to leave the comment below.
- 5:46And if you want to see, I'll see you later!
TRT on TikTok: separating real hormone science from hype
Quick answer
This video is tagged under TRT and testosterone replacement therapy but contains no identifiable or coherent medical claims due to severe transcript degradation. Viewers interested in TRT should know that clinical guidelines from the Endocrine Society and AUA require two morning serum testosterone readings below 300 ng/dL plus symptomatic confirmation before initiating therapy. Off-label use of testosterone for age-related decline or performance purposes carries documented risks including fertility suppression, polycythemia, and cardiovascular effects that are not adequately represented in most social media content on this topic.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT on TikTok: separating real hormone science from hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT on TikTok: separating real hormone science from hype is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT on TikTok: separating real hormone science from hype" from EL FARMACOLOGO. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This video is tagged under TRT and testosterone replacement therapy but contains no identifiable or coherent medical claims due to severe transcript degradation.
The reason this review is not generic is the source wording and the canonical claim label "trt respuesta a davidgaray140." In this clip, the useful excerpt is: "Aver dis a ." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
This video is tagged under TRT and testosterone replacement therapy but contains no identifiable or coherent medical claims due to severe transcript degradation.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- This video is tagged under TRT and testosterone replacement therapy but contains no identifiable or coherent medical claims due to severe transcript degradation. Viewers interested in TRT should know that clinical guidelines from the Endocrine Society and AUA require two morning serum testosterone readings below 300 ng/dL plus symptomatic confirmation before initiating therapy. Off-label use of testosterone for age-related decline or performance purposes carries documented risks including fertility suppression, polycythemia, and cardiovascular effects that are not adequately represented in most social media content on this topic.
- The Endocrine Society requires two separate morning serum testosterone readings below 300 ng/dL plus symptoms to diagnose hypogonadism before TRT is indicated.
- The 2016 Testosterone Trials (Snyder et al., NEJM) found TRT improved sexual function and bone density in older hypogonadal men, but did not study performance-oriented off-label use.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The Endocrine Society requires two separate morning serum testosterone readings below 300 ng/dL plus symptoms to diagnose hypogonadism before TRT is indicated.
- The 2016 Testosterone Trials (Snyder et al., NEJM) found TRT improved sexual function and bone density in older hypogonadal men, but did not study performance-oriented off-label use.
- TRT suppresses endogenous testosterone production and significantly impairs sperm production; Lee et al. (Fertility and Sterility, 2011) found azoospermia in a substantial proportion of TRT users.
- The FDA updated testosterone labeling in 2015 to warn against use solely for age-related low testosterone without confirmed hypogonadism diagnosis.
- Most over-the-counter testosterone boosters lack rigorous clinical evidence; ashwagandha is among the better-studied options but shows only modest effects (Lopresti et al., Medicine, 2019).
- Compounded testosterone formulations are not interchangeable with FDA-approved products and carry additional variability in potency and sterility that patients should understand.
- This specific video's transcript was too incoherent to yield evaluable medical claims, which is itself a content quality concern for viewers seeking reliable TRT information.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @el_farma_cologo actually say?
Honestly? It is nearly impossible to tell. The transcript from this video is largely incoherent, a mix of garbled English, fragmented Spanish, and what appears to be heavy auto-transcription error layered on top of an already unclear delivery. There is no identifiable medical claim that can be attributed to this creator with any confidence.
The video was categorized under TRT and testosterone replacement therapy, and the caption indicates it is a reply to another user. But nothing in the transcript clearly addresses testosterone, hypogonadism, hormone optimization, or any related clinical topic. Phrases like "it is very natural" and "it is very famous for the live" appear, but these cannot be responsibly interpreted as medical claims. The Spanish segments are similarly fragmented and do not form coherent medical statements.
This is not a criticism of the creator's language ability. This is a problem with the transcript quality. Without a reliable source text, any fact-check risks putting words in someone's mouth, and we are not going to do that.
Does the science back this up?
There is nothing coherent enough here to test against the literature. That said, since the video is tagged under TRT, it is worth briefly grounding what the actual science says in this space, so viewers landing here have something useful.
Testosterone replacement therapy for hypogonadism is one of the better-studied areas in men's health endocrinology. The 2018 Testosterone Trials (Snyder et al., New England Journal of Medicine, 2016) established meaningful benefits for sexual function and bone density in older hypogonadal men. The AUA and Endocrine Society both publish clinical guidelines supporting TRT for confirmed hypogonadism diagnosed via two morning serum testosterone readings below 300 ng/dL, combined with symptoms.
What the science does not support is the broader "hormone optimization" framing that circulates heavily on TikTok, where TRT is discussed as a performance or lifestyle intervention for men with normal testosterone levels. That application has a much weaker evidence base and carries real cardiovascular and fertility risks that most viral content ignores entirely.
What did they get wrong (or right)?
We cannot fairly assign right or wrong to a transcript this degraded. Doing so would be irresponsible journalism. What we can say is this: the video's categorization under TRT signals intent to discuss a regulated medical topic, and the 30,000-plus views it accumulated mean real people watched it looking for health information.
If the creator did discuss natural testosterone support, cultural attitudes toward TRT in Mexico or Canada, or community-based approaches to hormone health, those are topics worth covering carefully. "Natural" testosterone boosters, for instance, are a minefield. Ashwagandha has some modest evidence behind it (Lopresti et al., Medicine, 2019), but most supplements marketed for testosterone are not backed by rigorous human trials. D-aspartic acid, zinc superdosing, and herbal blends rarely move the needle clinically in men with actual hypogonadism.
If the creator's point was that TRT culture differs between countries, that is genuinely true and interesting. Mexico has different regulatory structures around testosterone access than Canada or the US, and that has real implications for patient safety and drug quality.
What should you actually know?
If you found this video through an interest in TRT, here is what is actually worth knowing. Testosterone replacement is a legitimate, guideline-supported treatment for men with clinically confirmed hypogonadism. It is not a supplement. It is not a lifestyle hack. It is a hormone therapy with real benefits and real risks.
Risks include suppression of natural testosterone production, reduced sperm count and fertility (Lee et al., Fertility and Sterility, 2011), elevated hematocrit, and in some populations, cardiovascular considerations that are still being studied. The FDA updated its labeling requirements in 2015 specifically because of concerns about off-label use in age-related decline rather than true hypogonadism.
If you are considering TRT, the appropriate path is a confirmed lab diagnosis, a conversation with a licensed provider, and ongoing monitoring of hematocrit, PSA, and lipid panels. A TikTok video, regardless of creator credentials, is not a substitute for that process.
- Get two morning testosterone tests before any treatment decision.
- Understand that "low T" symptoms overlap with depression, sleep apnea, and thyroid disorders, all of which need to be ruled out.
- Compounded testosterone products are not equivalent to FDA-approved formulations in terms of regulatory oversight.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
EL FARMACOLOGO · TikTok creator
30.4K views on this video
Respuesta a @davidgaray140
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the endocrine society requires two separate morning serum testosterone readings?
The Endocrine Society requires two separate morning serum testosterone readings below 300 ng/dL plus symptoms to diagnose hypogonadism before TRT is indicated.
What does the video say about the 2016 testosterone trials (snyder et al., nejm) found trt?
The 2016 Testosterone Trials (Snyder et al., NEJM) found TRT improved sexual function and bone density in older hypogonadal men, but did not study performance-oriented off-label use.
What does the video say about trt suppresses endogenous testosterone production?
TRT suppresses endogenous testosterone production and significantly impairs sperm production; Lee et al. (Fertility and Sterility, 2011) found azoospermia in a substantial proportion of TRT users.
What does the video say about the fda updated testosterone labeling in 2015 to warn against?
The FDA updated testosterone labeling in 2015 to warn against use solely for age-related low testosterone without confirmed hypogonadism diagnosis.
What does the video say about most over-the-counter testosterone boosters lack rigorous clinical evidence; ashwagandha?
Most over-the-counter testosterone boosters lack rigorous clinical evidence; ashwagandha is among the better-studied options but shows only modest effects (Lopresti et al., Medicine, 2019).
What does the video say about compounded testosterone formulations?
Compounded testosterone formulations are not interchangeable with FDA-approved products and carry additional variability in potency and sterility that patients should understand.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by EL FARMACOLOGO, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.